Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Alvesco
Active Ingredient: Ciclesonide 160Ág/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: St Ives Medical
Manufacturer: 3M Health Care (UK) Limited, Loughborough, Leicestershire, England
Product: Alvesco
Active Ingredient: Ciclesonide 40Ág/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: St Ives Medical
Manufacturer: 3M Health Care (UK) Limited, Loughborough, Leicestershire, England
Product: Alvesco
Active Ingredient: Ciclesonide 80Ág/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: St Ives Medical
Manufacturer: 3M Health Care (UK) Limited, Loughborough, Leicestershire, England
Product: m-Ciprofloxacin
Active Ingredient: Ciprofloxacin lactate 2.55mg/mL equivalent to ciprofloxacin 2mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Demo SA, Kryoneri, Athens, Greece
Product: m-Morphine
Active Ingredient: Morphine sulphate 1mg/mL equivalent to morphine 0.752mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Hameln Pharmaceuticals GmbH, Hameln, Germany
Product: m-Morphine
Active Ingredient: Morphine sulphate 10mg/mL equivalent to morphine 7.52 mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Hameln Pharmaceuticals GmbH, Hameln, Germany
Product: m-Morphine
Active Ingredient: Morphine sulphate 15mg/mL equivalent to morphine 11.28mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Hameln Pharmaceuticals GmbH, Hameln, Germany
Dated this 9th day of December 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).